Rethinking Glucose Role in Alzheimer's Disease Based on the Disease Incidence in Diabetes Type 2 Patients
Zefat Academics Kibbutz Eilon, Galil Maaravi, Israel
- *Corresponding Author:
- Amos Gelbard
Zefat Academics Kibbutz Eilon
Galil Maaravi, Israel
E-mail: [email protected]
Received Date: March 21, 2017; Accepted Date: April 01, 2017; Published Date: April 03, 2017
Citation: Gelbard A (2017) Rethinking Glucose Role in Alzheimer's Disease Based on the Disease Incidence in Diabetes Type 2 Patients. J Gerontol Geriatr Res 6: 414. doi:10.4172/2167-7182.1000414
Copyright: © 2017 Gelbard A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
In a previous essay, I explained why Alzheimer’s Disease (AD) is a result of high cortisol levels, that through time cause defects in the enzymes responsible to the proper peptide of beta-amyloid-alpha, beta and gamma secretases-and consequently to the accumulation of beta-amyloid within the neurons which results in Alzheimer's Disease.